Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterCorrespondence

Dr. Thompson and Dr. Graydon reply

ANDY E. THOMPSON and SARA L. GRAYDON
The Journal of Rheumatology April 2009, 36 (4) 853; DOI: https://doi.org/10.3899/jrheum.081215
ANDY E. THOMPSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: andy.thompson@rogers.com
SARA L. GRAYDON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

To the Editor:

We thank Dr. Bernatsky and colleagues for sharing their work and insightful comments. As discussed in their letter, one of the commonly emerging themes from focus group discussions regarding timely rheumatologic referral is the value of communication between patient, referring physician, and rheumatologist. We believe our study highlights the fact that accurate communication is missing between primary care physicians and rheumatologists. How to best improve communication between these parties is debated.

As clinical educators, we believe that local continuing medical education (CME) is always a rewarding opportunity to deliver a message and create links with the participants. However, global improvement in access to rheumatologic care through CME at the primary care level would likely be inefficient. Effective CME utilizing nondidactic techniques in multiple sequenced sessions is very costly in terms of time and resources.

We are currently pilot-testing a simple one-page rheumatologic referral tool with the goal of improving communication between primary care physicians and rheumatologists. We have sent this tool to 800 local family doctors and have collected 1000 referrals in our database. We are in the preliminary phases of analyzing our data; a few preliminary themes have emerged: (1) Motivating primary care physicians to consistently use the referral tool has been challenging. This strategy was launched with multiple single CME sessions on the use of the referral tool. (2) Despite clearly asking for information, communication remains a problem. Examination of 900 referrals revealed that fewer than 50% of referring physicians included a simple complete blood count with the referral (when it was clearly asked for).

In what direction should we move? It is clear that rheumatology needs a national strategy to improve the referral process. All rheumatologists mandating referring physicians to use a validated general rheumatology referral form would be a significant step forward in improving the referral process. This strategy would require referring physicians to change behavior, while providing education through repetitive use of the form supported by Web-based and local CME.

Footnotes

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 36, Issue 4
1 Apr 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dr. Thompson and Dr. Graydon reply
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dr. Thompson and Dr. Graydon reply
ANDY E. THOMPSON, SARA L. GRAYDON
The Journal of Rheumatology Apr 2009, 36 (4) 853; DOI: 10.3899/jrheum.081215

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Dr. Thompson and Dr. Graydon reply
ANDY E. THOMPSON, SARA L. GRAYDON
The Journal of Rheumatology Apr 2009, 36 (4) 853; DOI: 10.3899/jrheum.081215
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • To the Editor:
    • Footnotes
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Post SARS-CoV-2 Vaccine Chilblains-like Lesions
  • A Case of Scleromyxedema Development Following Intravesical Bacillus Calmette-Guérin Administration
  • Dr. Li et al reply
Show more Correspondence

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire